We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Collaboration to Promote Study of the Role of Structural Biology in Disease

By LabMedica International staff writers
Posted on 25 Jan 2012
A major manufacturer of electron microscopes has joined a cooperative research initiative to combine this method with NMR (nuclear magnetic resonance) spectroscopy and X-ray diffraction to accelerate medical discoveries in the fields of infectious diseases and cancer.

The electron microscope manufacturer FEI (Hillsboro, OR, USA) has entered into a Cooperative Research and Development Agreement (CRADA) with the [US] National Institutes of Health (Bethesda, MD, USA), to create a “Living Lab Structural Biology Center” to promote structural biology research through the integration of cryoelectron microscopy (EM), NMR spectroscopy, and X-ray diffraction (XRD).

The research program, which will be centered on the campus of the [US] National Institutes of Health, will be empowered by FEI's Titan Krios transmission electron microscope (TEM), the world's most powerful commercially-available electron microscope for structural biology.

The collaboration effort will focus on the development of methods and workflows, from sample preparation through data analysis, which combine information from cryo-EM, XRD, and NMR. More...
Researchers have historically relied on NMR and XRD techniques to determine the structures of molecular complexes and proteins that play a role in the causes of various disease states. Structural information about a variety of medically important proteins and drugs has been obtained by NMR and XRD methods. Cryo-EM is a complementary analytical technique that provides near-atomic resolution without requirements for crystallization or limits on molecular size and complexity imposed by the other techniques.

Dr. Don Kania, president and CEO of FEI, said, “This collaborative effort with NIH is a critical part of our strategy to provide complete microscopy solutions for life science research. Our life sciences business has been increasing rapidly and is a key part of our overall corporate growth plan. Helping our customers to obtain increased value from electron microscopy in conjunction with and complementary to XRD and NMR is a key element of that plan.”

Related Links:

FEI
National Institutes of Health



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Multi-Chamber Washer-Disinfector
WD 390
New
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Mycobacterium tuberculosis bacteria seen with a scanning electron microscope (Credit: CDC PHIL)

Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection

Active tuberculosis (TB) remains a leading cause of death and illness worldwide, yet distinguishing contagious disease from latent infection continues to challenge clinicians. Standard screening tools... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.